Comparative <i>In Vitro</i> Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates

Tsai‐Ling Lauderdale, Yih‐Ru Shiau, Jui‐Fen Lai, Hua‐Chien Chen, Chi-Hsin R. King

Antimicrobial Agents and Chemotherapy · 2010 · 68 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

The in vitro antibacterial activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, against 770 clinical isolates were investigated. Nemonoxacin (tested as its malate salt, TG-875649) showed better in vitro activity than ciprofloxacin and levofloxacin against different species of staphylococci, streptococci, and enterococci, Neisseria gonorrhoeae, and Haemophilus influenzae. The in vitro activity of TG-875649 was also comparable to or better than that of moxifloxacin against these pathogens, which included ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus and levofloxacin-resistant Streptococcus pneumoniae.

References

5